1.
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
Shin, DM, Mao, L, Papadimitrakopoulou, VM, Clayman, G, El-Naggar, A, Shin, HJ, Lee, JJ, Lee, JS, Gillenwater, A, Myers, J, et al
Journal of the National Cancer Institute. 2000;(1):69-73